Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival.
Priyanka NarayanCaroline E KostrzewaZhigang ZhangDiana A Roth O'BrienBoris A MuellerJohn J CuaronAmy J XuMichael B BernsteinBeryl McCormickSimon N PowellAtif J KhanHannah Y WenLior Z BraunsteinPublished in: Breast cancer research and treatment (2023)
Appropriately-treated MBC may exhibit recurrence and survival outcomes that are difficult to distinguish from those of non-MBC. While prior studies suggest that MBC has a worse natural history than non-MBC triple-negative breast cancer, prudent use of chemotherapy and radiotherapy may narrow these differences, although studies with more power will be required to inform clinical management. Longer follow-up among larger populations may further elucidate the clinical and therapeutic implications of MBC.